BNP Paribas Financial Markets’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10M | Sell |
269,383
-58,074
| -18% | -$1.76M | ﹤0.01% | 1644 |
|
|
2026
Q1 | $11.1M | Buy |
327,457
+84,787
| +35% | +$2.4M | 0.01% | 1512 |
|
|
2025
Q4 | $6.61M | Buy |
242,670
+227,972
| +1,551% | +$8M | ﹤0.01% | 1861 |
|
|
2025
Q3 | $590K | Buy |
14,698
+2,790
| +23% | +$105K | ﹤0.01% | 3458 |
|
|
2025
Q2 | $396K | Buy |
11,908
+7,572
| +175% | +$230K | ﹤0.01% | 3472 |
|
|
2025
Q1 | $127K | Sell |
4,336
-5,368
| -55% | -$178K | ﹤0.01% | 3950 |
|
|
2024
Q4 | $319K | Sell |
9,704
-2,242
| -19% | -$105K | ﹤0.01% | 3589 |
|
|
2024
Q3 | $531K | Buy |
11,946
+1,570
| +15% | +$71.3K | ﹤0.01% | 2833 |
|
|
2024
Q2 | $447K | Sell |
10,376
-21,199
| -67% | -$765K | ﹤0.01% | 2727 |
|
|
2024
Q1 | $923K | Sell |
31,575
-93,734
| -75% | -$2.51M | ﹤0.01% | 2548 |
|
|
2023
Q4 | $2.79M | Buy |
125,309
+66,070
| +112% | +$1.48M | ﹤0.01% | 1744 |
|
|
2023
Q3 | $1.47M | Sell |
59,239
-6,241
| -10% | -$165K | ﹤0.01% | 2079 |
|
|
2023
Q2 | $1.85M | Sell |
65,480
-45,386
| -41% | -$1.13M | ﹤0.01% | 1798 |
|
|
2023
Q1 | $2.55M | Buy |
110,866
+45,318
| +69% | +$1.2M | ﹤0.01% | 1661 |
|
|
2022
Q4 | $1.84M | Sell |
65,548
-76,859
| -54% | -$2.17M | ﹤0.01% | 1818 |
|
|
2022
Q3 | $4.03M | Buy |
142,407
+41,379
| +41% | +$1.11M | 0.01% | 1480 |
|
|
2022
Q2 | $2.24M | Buy |
101,028
+72,820
| +258% | +$1.64M | ﹤0.01% | 1688 |
|
|
2022
Q1 | $821K | Sell |
28,208
-7,393
| -21% | -$226K | ﹤0.01% | 2451 |
|
|
2021
Q4 | $1.17M | Buy |
35,601
+7,879
| +28% | +$317K | ﹤0.01% | 2486 |
|
|
2021
Q3 | $1.28M | Buy |
27,722
+7,280
| +36% | +$352K | ﹤0.01% | 2210 |
|
|
2021
Q2 | $1.13M | Buy |
20,442
+2,241
| +12% | +$125K | ﹤0.01% | 2112 |
|
|
2021
Q1 | $940K | Sell |
18,201
-3,291
| -15% | -$163K | ﹤0.01% | 2167 |
|
|
2020
Q4 | $931K | Sell |
21,492
-102,925
| -83% | -$4.07M | ﹤0.01% | 2065 |
|
|
2020
Q3 | $4.35M | Sell |
124,417
-40,527
| -25% | -$1.78M | 0.01% | 1157 |
|
|
2020
Q2 | $8.82M | Sell |
164,944
-5,677
| -3% | -$263K | 0.02% | 768 |
|
|
2020
Q1 | $6.05M | Sell |
170,621
-118,805
| -41% | -$5.49M | 0.01% | 892 |
|
|
2019
Q4 | $13.8M | Buy |
289,426
+273,577
| +1,726% | +$10.3M | 0.03% | 669 |
|
|
2019
Q3 | $514K | Buy |
15,849
+2,150
| +16% | +$89K | ﹤0.01% | 2193 |
|
|
2019
Q2 | $683K | Sell |
13,699
-22
| -0.2% | -$1.18K | ﹤0.01% | 1869 |
|
|
2019
Q1 | $925K | Buy |
13,721
+2,000
| +17% | +$116K | ﹤0.01% | 1737 |
|
|
2018
Q4 | $540K | Buy |
11,721
+2,309
| +25% | +$143K | ﹤0.01% | 1782 |
|
|
2018
Q3 | $726K | Buy |
9,412
+237
| +3% | +$19.1K | ﹤0.01% | 1870 |
|
|
2018
Q2 | $773K | Sell |
9,175
-914
| -9% | -$79.7K | ﹤0.01% | 1831 |
|
|
2018
Q1 | $825K | Buy |
10,089
+11
| +0.1% | +$850 | ﹤0.01% | 1878 |
|
|
2017
Q4 | $576K | Sell |
10,078
-2,138
| -18% | -$135K | ﹤0.01% | 2372 |
|
|
2017
Q3 | $815K | Sell |
12,216
-1,359
| -10% | -$81.6K | ﹤0.01% | 1689 |
|
|
2017
Q2 | $698K | Buy |
13,575
+385
| +3% | +$19.7K | ﹤0.01% | 1723 |
|
|
2017
Q1 | $770K | Buy |
13,190
+1,950
| +17% | +$93.5K | ﹤0.01% | 1495 |
|
|
2016
Q4 | $469K | Sell |
11,240
-3,148
| -22% | -$165K | ﹤0.01% | 1728 |
|
|
2016
Q3 | $760K | Buy |
14,388
+2,440
| +20% | +$106K | ﹤0.01% | 1020 |
|
|
2016
Q2 | $501K | Sell |
11,948
-74
| -0.6% | -$3.65K | ﹤0.01% | 1512 |
|
|
2016
Q1 | $488K | Buy |
12,022
+2,613
| +28% | +$112K | ﹤0.01% | 1204 |
|
|
2015
Q4 | $611K | Buy |
9,409
+2,034
| +28% | +$133K | ﹤0.01% | 1053 |
|
|
2015
Q3 | $521K | Sell |
7,375
-193
| -3% | -$18.9K | ﹤0.01% | 1335 |
|
|
2015
Q2 | $841K | Buy |
7,568
+7,223
| +2,094% | +$778K | ﹤0.01% | 1173 |
|
|
2015
Q1 | $32.5K | Buy |
+345
| New | +$38.7K | ﹤0.01% | 2136 |
|
|
2014
Q4 | – | Sell |
-994
| Closed | -$61K | – | 2011 |
|
|
2014
Q3 | $61K | Buy |
+994
| New | +$42.8K | ﹤0.01% | 2475 |
|
|
2014
Q2 | – | Sell |
-36
| Closed | -$1.51K | – | 3819 |
|
|
2014
Q1 | $1.51K | Buy |
36
+8
| +29% | +$268 | ﹤0.01% | 2749 |
|
|
2013
Q4 | $671 | Buy |
+28
| New | +$638 | ﹤0.01% | 3903 |
|
Other funds holding AGIO
FCM
LCM
AC
EAM
NAMI
BNP Paribas Financial Markets's AGIO Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Agios Pharmaceuticals (AGIO) stake by 18% in Q2 2026, selling an estimated $1.76M and leaving 269,383 shares worth $10M. The position accounts for ﹤0.01% of the portfolio, ranked #1644.
BNP Paribas Financial Markets first reported a position in AGIO in Q4 2013 and has held it in 49 quarters since. The position peaked at $13.8M in Q4 2019. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.
- BNP Paribas Financial Markets held 269,383 shares of Agios Pharmaceuticals worth $10M as of Q2 2026.
- BNP Paribas Financial Markets sold 58,074 Agios Pharmaceuticals shares in Q2 2026, an estimated $1.76M.
- Agios Pharmaceuticals made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1644 holding.
- BNP Paribas Financial Markets first reported a position in Agios Pharmaceuticals in Q4 2013 and has held it in 49 quarters since.
- BNP Paribas Financial Markets's Agios Pharmaceuticals position peaked at $13.8M in Q4 2019.
- 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.